Importer of Controlled Substances Application: United States, 15175-15176 [2018-07167]
Download as PDF
<![CDATA[
15175
Federal Register / Vol. 83, No. 68 / Monday, April 9, 2018 / Notices
Dated: April 3, 2018.
Elizabeth K. Appel,
Director, Office of Regulatory Affairs and
Collaborative Action—Indian Affairs.
[FR Doc. 2018–07122 Filed 4–6–18; 8:45 am]
BILLING CODE 4337–15–P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—UHD Alliance, Inc.
Notice is hereby given that, on March
8, 2018, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), UHD Alliance, Inc.
(‘‘UHD Alliance’’) filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Google, Inc., Mountain
View, CA; Teledyne LeCroy, Elgin, IL;
and Synaptics, San Jose, CA, have been
added as parties to this venture.
Also, HDAnywhere Ltd., Malvern,
UNITED KINGDOM; Quantum Data,
Inc., Elgin, IL; and Sky UK Ltd.,
Isleworth, UNITED KINGDOM, have
withdrawn as parties to this venture.
In addition, the following members
have changed their names: Koninklijke
Philips N.V. to Philips International
B.V.–IP&S, Eindhoven,
NETHERLANDS; and DTS, Inc., to
Xperi Corporation, Calabasas, CA.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and UHD Alliance
intends to file additional written
notifications disclosing all changes in
membership.
On June 17, 2015, UHD Alliance filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on July 17, 2015 (80 FR
42537).
The last notification was filed with
the Department on December 15, 2017.
A notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on February 12, 2018 (83 FR 6051).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2018–07129 Filed 4–6–18; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: United States
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 9, 2018. Such persons
may also file a written request for a
hearing on the application on or before
May 9, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
DATES:
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
delegated to the Assistant Administrator
of the DEA Diversion Control Division
(‘‘Assistant Administrator’’) pursuant to
section 7 of 28 CFR part 0, appendix to
subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on March
1, 2018, United States Pharmacopeial
Convention, 12601 Twinbrook Parkway,
Rockville, MD, 20852 applied to be
registered as an importer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
sradovich on DSK3GMQ082PROD with NOTICES
Controlled substance
Drug code
Cathinone ........................................................................................................................................................................
Methaqualone ..................................................................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .............................................................................................................................
4-Methoxyamphetamine ..................................................................................................................................................
Codeine-N-oxide ..............................................................................................................................................................
Difenoxin ..........................................................................................................................................................................
Heroin ..............................................................................................................................................................................
Morphine-N-oxide ............................................................................................................................................................
Norlevorphanol ................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
Phenmetrazine .................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Glutethimide .....................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Phenylacetone .................................................................................................................................................................
Alphaprodine ....................................................................................................................................................................
Anileridine ........................................................................................................................................................................
Cocaine ............................................................................................................................................................................
VerDate Sep<11>2014
18:06 Apr 06, 2018
Jkt 244001
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
E:\FR\FM\09APN1.SGM
09APN1
1235
2565
7315
7395
7411
9053
9168
9200
9307
9634
1105
1631
1724
2125
2270
2315
2550
7471
8501
9010
9020
9041
Schedule
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
15176
Federal Register / Vol. 83, No. 68 / Monday, April 9, 2018 / Notices
Controlled substance
Drug code
Dihydrocodeine ................................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Levomethorphan ..............................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Thebaine ..........................................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Alfentanil ..........................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
The company plans to import the bulk
controlled substances for distribution of
analytical reference standards to its
customers for research and analytical
purposes.
Dated: April 2, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018–07167 Filed 4–6–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: AMRI Rensselaer, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
DATES:
or before May 9, 2018. Such persons
may also file a written request for a
hearing on the application on or before
May 9, 2018.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
delegated to the Assistant Administrator
of the DEA Diversion Control Division
(‘‘Assistant Administrator’’) pursuant to
section 7 of 28 CFR part 0, appendix to
subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on March
21, 2018, AMRI Rensselaer, 33 Riverside
Ave., Rensselaer, NY 12144, applied to
be registered as an importer of the
following basic class of controlled
substance:
Drug code
Poppy Straw Concentrate ...............................................................................................................................................
Dated: April 2, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018–07165 Filed 4–6–18; 8:45 am]
sradovich on DSK3GMQ082PROD with NOTICES
BILLING CODE 4410–09–P
NATIONAL FOUNDATION ON THE
ARTS AND THE HUMANITIES
Arts Advisory Panel Meetings
National Endowment for the
Arts, National Foundation on the Arts
and Humanities.
VerDate Sep<11>2014
18:06 Apr 06, 2018
Jkt 244001
Notice of meetings.
Pursuant to the Federal
Advisory Committee Act, as amended,
notice is hereby given that 2 meetings of
the Arts Advisory Panel to the National
Council on the Arts will be held by
teleconference unless otherwise noted.
DATES: See the SUPPLEMENTARY
INFORMATION section for individual
meeting times and dates. All meetings
are Eastern time and ending times are
approximate:
SUMMARY:
National Endowment for the
Arts, Constitution Center, 400 7th St.
SW, Washington, DC 20506.
FOR FURTHER INFORMATION CONTACT:
Further information with reference to
these meetings can be obtained from Ms.
Sherry P. Hale, Office of Guidelines &
Panel Operations, National Endowment
ADDRESSES:
National Endowment for the Arts
AGENCY:
ACTION:
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
II
II
SUPPLEMENTARY INFORMATION:
Controlled substance
The company plans to import the
listed controlled substance to
manufacture bulk controlled substance
for distribution to its customers.
9120
9170
9210
9220
9230
9273
9333
9668
9737
9740
Schedule
9670
Schedule
II
for the Arts, Washington, DC 20506;
hales@arts.gov, or call 202/682–5696.
The
closed portions of meetings are for the
purpose of Panel review, discussion,
evaluation, and recommendations on
financial assistance under the National
Foundation on the Arts and the
Humanities Act of 1965, as amended,
including information given in
confidence to the agency. In accordance
with the determination of the Chairman
of July 5, 2016, these sessions will be
closed to the public pursuant to
subsection (c)(6) of section 552b of title
5, United States Code.
The upcoming meetings are:
Literature Fellowships: Translation
Projects (review of applications): This
meeting will be closed. Date and time:
May 16, 2018; 3:00 p.m. to 5:00 p.m.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\09APN1.SGM
09APN1
]]>Agencies
[Federal Register Volume 83, Number 68 (Monday, April 9, 2018)]
[Notices]
[Pages 15175-15176]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07167]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: United States
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before May 9, 2018. Such
persons may also file a written request for a hearing on the
application on or before May 9, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been delegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on March
1, 2018, United States Pharmacopeial Convention, 12601 Twinbrook
Parkway, Rockville, MD, 20852 applied to be registered as an importer
of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone................................ 1235 I
Methaqualone............................. 2565 I
Lysergic acid diethylamide............... 7315 I
4-Methyl-2,5-dimethoxyamphetamine........ 7395 I
4-Methoxyamphetamine..................... 7411 I
Codeine-N-oxide.......................... 9053 I
Difenoxin................................ 9168 I
Heroin................................... 9200 I
Morphine-N-oxide......................... 9307 I
Norlevorphanol........................... 9634 I
Methamphetamine.......................... 1105 II
Phenmetrazine............................ 1631 II
Methylphenidate.......................... 1724 II
Amobarbital.............................. 2125 II
Pentobarbital............................ 2270 II
Secobarbital............................. 2315 II
Glutethimide............................. 2550 II
Phencyclidine............................ 7471 II
Phenylacetone............................ 8501 II
Alphaprodine............................. 9010 II
Anileridine.............................. 9020 II
Cocaine.................................. 9041 II
[[Page 15176]]
Dihydrocodeine........................... 9120 II
Diphenoxylate............................ 9170 II
Levomethorphan........................... 9210 II
Levorphanol.............................. 9220 II
Meperidine............................... 9230 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Thebaine................................. 9333 II
Noroxymorphone........................... 9668 II
Alfentanil............................... 9737 II
Sufentanil............................... 9740 II
------------------------------------------------------------------------
The company plans to import the bulk controlled substances for
distribution of analytical reference standards to its customers for
research and analytical purposes.
Dated: April 2, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-07167 Filed 4-6-18; 8:45 am]
BILLING CODE 4410-09-P
